No Data
No Data
No Data
No Data
No Data
Watching Eledon Pharmaceuticals, Acumen Pharmaceuticals; Shares See Volume On TipRanks Article Titled "These 2 'Strong Buy' Penny Stocks Are Poised for Over 300% Gains, Say Analysts"
Watching Eledon Pharmaceuticals, Acumen Pharmaceuticals; Shares See Volume On TipRanks Article Titled "These 2 'Strong Buy' Penny Stocks Are Poised for Over 300% Gains, Say Analysts"
BenzingaApr 18 23:41
Eledon Pharmaceuticals Risks Shareholder Equity Dilution Amidst Private Placement and Potential Stock Issuances
Eledon Pharmaceuticals, Inc. (ELDN) has disclosed a new risk, in the Share Price & Shareholder Rights category.
TipRanksMar 30 14:02
Eledon Pharmaceuticals: A Strong Buy on the Back of Promising Clinical Trials and a Solid Financial Footing
TipRanksMar 29 05:55
Eledon Pharma Q4 2023 GAAP EPS $(0.32) Beats $(0.39) Estimate
Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39) by 17.95 percent.
BenzingaMar 29 04:07
Eledon PhaDrmaceuticals 4Q Loss/Shr 32c >ELDN
Eledon PhaDrmaceuticals 4Q Loss/Shr 32c >ELDN
Dow JonesMar 29 04:02
Press Release: Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results Enrolled 12 participants in Phase 2 BESTOW trial evaluating tegoprubart for the prevention of kidney r
Dow JonesMar 29 04:01
No Data
No Data